retatrutide clinical trial obesity results for retatrutide, Eli Lilly's next weight loss drug, showed far more weight loss than other blockbuster drugs. More below ⬇️ Retatrutide Phase 3: 60% Achieved
Description
This evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long term weight control, say the researchers
Additional information Competing interests The authors declare that they have no competing interests
Rybelsus is TGA-approved for type 2 diabetes, not for weight loss
2024 Sep 18;9(1):234
So the official answer is this: tirzepatide does not require strict lifestyle changes to show results
What milliliters actually measure Milliliters measure the volume of liquid you draw into the syringe
